Shilpa Medicare Limited has announced a board meeting to consider and approve the financial results for the quarter and nine months ended December 31, 2024. In line with SEBI regulations, the trading window for the company’s shares will be closed from January 1, 2025, until 48 hours after the results are declared. This move aims to ensure compliance with insider trading regulations. Investors should be mindful of the potential risk stemming from the trading halt as it may limit short-term trading activity, but could also present opportunities post-announcement based on earnings performance.